Suppr超能文献

单孔电视辅助胸腔镜手术治疗原发性肺癌的可行性与安全性

Feasibility and Safety of Single-Port Video-Assisted Thoracic Surgery for Primary Lung Cancer.

作者信息

Heo Woon, Kang Do Kyun, Min Ho-Ki, Jun Hee Jae, Hwang Youn-Ho

机构信息

Department of Thoracic and Cardiovascular Surgery, Inje University Haeundae Paik Hospital, Inje University College of Medicine.

出版信息

Korean J Thorac Cardiovasc Surg. 2017 Jun;50(3):190-196. doi: 10.5090/kjtcs.2017.50.3.190. Epub 2017 Jun 5.

Abstract

BACKGROUND

The feasibility of single-port video-assisted thoracic surgery (SPVATS) for primary lung cancer is not well understood. In this study, we compared SP and multi-port (MP) VATS for the surgical treatment of patients with primary lung cancer.

METHODS

Surgical treatment was performed in 181 patients with primary lung cancer at Inje University Haeundae Paik Hospital between June 2012 and December 2015. A propensity-matched analysis was used to compare the postoperative outcomes and to evaluate the comparative feasibility and safety of SPVATS and MPVATS.

RESULTS

There were 37 patients in the SPVATS group and 67 patients in the MPVATS group. Propensity matching produced 32 pairs. The operation time (210 minutes versus 200 minutes, p=0.11), volume of the estimated blood loss (170 mL versus 160 mL, p=0.19), duration of chest tube drainage (5 days versus 6 days, p=0.66), and length of hospital stay (9 days versus 10 days, p=0.89) were similar between the 2 groups.

CONCLUSION

In our study, SPVATS for primary lung cancer was safe and feasible in well selected patients. A prospective, randomized study with a large group and long-term follow-up is necessary to evaluate the clinical feasibility and the advantages of SPVATS for primary lung cancer.

摘要

背景

单孔电视辅助胸腔镜手术(SPVATS)用于原发性肺癌的可行性尚未得到充分了解。在本研究中,我们比较了单孔和多孔(MP)VATS用于原发性肺癌患者的手术治疗情况。

方法

2012年6月至2015年12月期间,在仁济大学海云台白医院对181例原发性肺癌患者进行了手术治疗。采用倾向匹配分析来比较术后结果,并评估SPVATS和MPVATS的相对可行性和安全性。

结果

SPVATS组有37例患者,MPVATS组有67例患者。倾向匹配产生了32对。两组之间的手术时间(210分钟对200分钟,p = 0.11)、估计失血量(170 mL对160 mL,p = 0.19)、胸管引流持续时间(5天对6天,p = 0.66)和住院时间(9天对10天,p = 0.89)相似。

结论

在我们的研究中,SPVATS用于原发性肺癌在精心挑选的患者中是安全可行的。有必要进行一项大样本、长期随访的前瞻性随机研究,以评估SPVATS用于原发性肺癌的临床可行性和优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/173f/5460966/166121d0be25/kjtcvs-50-190f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验